The six-step de novo pyrimidine biosynthesis pathway converts aspartate and bicarbonate into UMP. The first step produces carbamoyl phosphate from glutamine and bicarbonate. Carbamoyl phosphate then reacts with aspartate to form carbamoyl aspartate. Ring closure produces dihydroorotate, which is oxidized to orotate. Orotate is attached to PRPP to form OMP. OMP is decarboxylated to produce the final product UMP. UMP can be further modified to CTP and other pyrimidine nucleotides. The pathway is regulated by feedback inhibition of early enzymes by end products.